155 related articles for article (PubMed ID: 26930230)
1. Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells.
Kulhari H; Pooja D; Kota R; Reddy TS; Tabor RF; Shukla R; Adams DJ; Sistla R; Bansal V
Mol Pharm; 2016 May; 13(5):1491-500. PubMed ID: 26930230
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.
Yalcin TE; Ilbasmis-Tamer S; Takka S
Int J Pharm; 2020 Apr; 580():119246. PubMed ID: 32205141
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
4. Natural polysaccharide functionalized gold nanoparticles as biocompatible drug delivery carrier.
Pooja D; Panyaram S; Kulhari H; Reddy B; Rachamalla SS; Sistla R
Int J Biol Macromol; 2015 Sep; 80():48-56. PubMed ID: 26093321
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.
Yin N; Yu H; Zhang X; Lv X
Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890
[TBL] [Abstract][Full Text] [Related]
6. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.
Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M
Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464
[TBL] [Abstract][Full Text] [Related]
7. Ameliorating the antitumor activity of gemcitabine against breast tumor using α
Tunki L; Ganthala PD; Pooja D; Andugulapati SB; Kulhari H; Sistla R; Bhargava SK
Drug Dev Ind Pharm; 2022 Aug; 48(8):384-396. PubMed ID: 36047536
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine.
Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers.
Lammers T; Subr V; Ulbrich K; Peschke P; Huber PE; Hennink WE; Storm G
Biomaterials; 2009 Jul; 30(20):3466-75. PubMed ID: 19304320
[TBL] [Abstract][Full Text] [Related]
10. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
[TBL] [Abstract][Full Text] [Related]
11. Designing Two-Dimensional Nanosheets for Improving Drug Delivery to Fucose-Receptor-Overexpressing Cancer Cells.
Gupta N; Jangid AK; Singh M; Pooja D; Kulhari H
ChemMedChem; 2018 Dec; 13(24):2644-2652. PubMed ID: 30371024
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
[TBL] [Abstract][Full Text] [Related]
13. Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line.
Yu X; Song Y; Di Y; He H; Fu D; Jin C
Sci Rep; 2016 Aug; 6():31539. PubMed ID: 27515795
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy.
Arya G; Vandana M; Acharya S; Sahoo SK
Nanomedicine; 2011 Dec; 7(6):859-70. PubMed ID: 21550422
[TBL] [Abstract][Full Text] [Related]
15. Design and fabrication of dual-targeted delivery system based on gemcitabine-conjugated human serum albumin nanoparticles.
Norouzi P; Amini M; Mottaghitalab F; Mirzazadeh Tekie FS; Dinarvand R; Mirzaie ZH; Atyabi F
Chem Biol Drug Des; 2020 Aug; 96(2):745-757. PubMed ID: 28640541
[TBL] [Abstract][Full Text] [Related]
16. Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment.
Yuan YG; Peng QL; Gurunathan S
Int J Nanomedicine; 2017; 12():6487-6502. PubMed ID: 28919750
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Polyglycerol-Derived Nano-Architectures as Delivery Platforms of Gemcitabine for Pancreatic Cancer.
Ray P; Ferraro M; Haag R; Quadir M
Macromol Biosci; 2019 Jul; 19(7):e1900073. PubMed ID: 31183964
[TBL] [Abstract][Full Text] [Related]
18. Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug.
Parsian M; Unsoy G; Mutlu P; Yalcin S; Tezcaner A; Gunduz U
Eur J Pharmacol; 2016 Aug; 784():121-8. PubMed ID: 27181067
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells.
Oliveira C; Neves NM; Reis RL; Martins A; Silva TH
Nanomedicine (Lond); 2018 Aug; 13(16):2037-2050. PubMed ID: 30189774
[TBL] [Abstract][Full Text] [Related]
20. Micellar nanoparticles loaded with gemcitabine and doxorubicin showed synergistic effect.
Liu D; Chen Y; Feng X; Deng M; Xie G; Wang J; Zhang L; Liu Q; Yuan P
Colloids Surf B Biointerfaces; 2014 Jan; 113():158-68. PubMed ID: 24077114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
